The Intrinsic Pathway of Apoptosis

作者: Scott H. Kaufmann

DOI: 10.1007/978-1-59745-221-2_1

关键词: Intrinsic apoptosisInhibitor of apoptosisCell biologyXIAPCytochrome cChemistryCaspaseMitochondrionProgrammed cell deathApoptosis

摘要: Virtually all anticancer drugs induce apoptosis in susceptible cell types. This biochemically distinct form of death reflects, large part, activation caspases, a family intracellular cysteine proteases. At least two separable processes, one starting with ligation specific surface receptors (so-called receptors) and the other involving release cytochrome c from mitochondria, result transduction various signals into caspase activity. The mitochondrial or intrinsic pathway appears to play predominant role apoptotic response drugs. Bcl-2 members regulate this by modulating key proapoptotic polypeptides, including second activator caspases (Smac)/direct inhibitor (IAP)-binding protein low pI (DIABLO), mitochondria. Several that facilitate permeabilization are transcriptional targets p53 tumor suppressor gene, providing partial explanation for ability DNA-damaging agents apoptosis. Other released cytoskeletal sites upon treatment paclitaxel loss adherence. antiapoptotic XIAP (X chromosome-linked IAP) binds procaspase 9 prevents its activation. gene encoding is activated nuclear factor-κB, contributing effects transcription factor. In chapter, components reviewed, alterations cancers described, evidence some these same might contribute drug resistance under certain circumstances discussed.

参考文章(289)
Christine K Bieszczad, Emily S Cleaveland, Jonathan P Park, Ruth W Craig, Thuluvancheri K Mohandas, Julie A Vrana, Yan Ma, An MCL1-overexpressing Burkitt Lymphoma Subline Exhibits Enhanced Survival on Exposure to Serum Deprivation, Topoisomerase Inhibitors, or Staurosporine but Remains Sensitive to 1-β-d-Arabinofuranosylcytosine Cancer Research. ,vol. 62, pp. 892- 900 ,(2002)
John C. Reed, Dysregulation of Apoptosis in Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2941- 2941 ,(1999) , 10.1200/JCO.1999.17.9.2941
Jijie Chai, Qi Wu, Eric Shiozaki, Srinivasa M. Srinivasula, Emad S. Alnemri, Yigong Shi, Crystal Structure of a Procaspase-7 Zymogen: Mechanisms of Activation and Substrate Binding Cell. ,vol. 107, pp. 399- 407 ,(2001) , 10.1016/S0092-8674(01)00544-X
Igor B Roninson, Tumor Cell Senescence in Cancer Treatment Cancer Research. ,vol. 63, pp. 2705- 2715 ,(2003)
Rebecca Liu, Carmen Page, David R. Beidler, Max S. Wicha, Gabriel Núñez, Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model American Journal of Pathology. ,vol. 155, pp. 1861- 1867 ,(1999) , 10.1016/S0002-9440(10)65505-8
Pierre-François Cartron, Tristan Gallenne, Gwenola Bougras, Fabien Gautier, Florence Manero, Patricia Vusio, Khaled Meflah, François M. Vallette, Philippe Juin, The First α Helix of Bax Plays a Necessary Role in Its Ligand-Induced Activation by the BH3-Only Proteins Bid and PUMA Molecular Cell. ,vol. 16, pp. 807- 818 ,(2004) , 10.1016/J.MOLCEL.2004.10.028
Yasuyuki Suzuki, Yuzuru Imai, Hiroshi Nakayama, Kazuko Takahashi, Koji Takio, Ryosuke Takahashi, A Serine Protease, HtrA2, Is Released from the Mitochondria and Interacts with XIAP, Inducing Cell Death Molecular Cell. ,vol. 8, pp. 613- 621 ,(2001) , 10.1016/S1097-2765(01)00341-0
William C. Earnshaw, Luis M. Martins, Scott H. Kaufmann, Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis Annual Review of Biochemistry. ,vol. 68, pp. 383- 424 ,(1999) , 10.1146/ANNUREV.BIOCHEM.68.1.383